News | Artificial Intelligence | March 05, 2020

CLEW Brings Groundbreaking AI-Powered Critical Care Solution to U.S. Market

As Covid-19 spreads, healthcare resources — especially in ICUs will be pressured. Limited resources will need to be strategically leveraged/managed, and AI/predictive analytics may hold the key.

CLEW announced that it will be demonstrating the industry’s first-ever AI-powered critical care solution

March 5, 2020 — CLEW announced that it will be demonstrating the industry’s first-ever AI-powered critical care solution at two major industry tradeshows: The Society of Critical Care Medicine’s (SCCM) 49th Critical Care Congress, Feb. 16-19, and at the HIMSS Conference, March 9-13. Both healthcare events are taking place in Orlando, Fla.

Clinicians at UMass and WakeMed are testing the use of AI/predictive analytics to risk-stratify ICU patients by acuity to optimize patient flows and deployment of clinical resources. CLEW is the first technology to provide clinical predictive intelligence 6-14 hours in advance. Pending FDA approved (filing completed), this technology represents the innovation healthcare system need to optimize scarce healthcare resources—every day and during a crisis.

The CLEW solution harnesses vast amounts of clinical and patient data in real-time to deliver highly accurate predictive clinical analytics. Using prediction models CLEW provides ICU and TeleICU providers with preemptive patient care information, enabling continuous patient risk stratification, acuity-based resource allocation, clinical optimization, and improved case volumes.

Commenting on the need for a meaningful breakthrough in the delivery of healthcare, CLEW founder and CEO Gal Salomon said, “Using artificial intelligence is the only way to create change that really moves the needle to deliver true patient value.  With its U.S. market launch, CLEW aims to help U.S. health systems improve clinical outcomes and the patient experience by shortening stays and improving efficiency while reducing costs.

Craig Lilly, M.D., vice-chair, Critical Care Operations and Director of the eICU program at UMass Memorial commented on the use of AI in critical care, “Rather than reacting or having alerts and alarms in the room that tells us that a patient is deteriorating, we know ahead of time so that we can intervene in a way that prevents the patient from ever having any symptoms in the first place. It's truly an advance.”

For more information: www.clewmed.com/

Related Content

#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

Getty Images

Feature | Coronavirus (COVID-19) | April 03, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Varian received FDA clearance for its Ethos therapy in February 2020. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Varian received FDA clearance for its Ethos therapy in February 2020, shown here displayed for the first time at ASTRO 2019. It is an adaptive intelligence solution that uses onboard AI in the treatment system to take the cone beam CT imaging on the system, compare it to the treatment plan and deliver an entire adaptive treatment plan in a typical 15-minute treatment time slot, from patient setup through treatment delivery.

Feature | Treatment Planning | April 03, 2020 | Dave Fornell, Editor
The traditional treatment planning process takes days to create an optimized radiation therapy delivery plan, but new
An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips’ TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. Photo by Dave Fornell

Feature | Radiology Imaging | April 02, 2020 | By Katie Caron
A new year — and decade — offers the opportunity to reflect on the advancements and challenges of years gone by and p
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus

Getty Images

Feature | Coronavirus (COVID-19) | April 02, 2020 | Jilan Liu and HIMSS Greater China Team
Information technologies have played a pivotal role in China’s response to the novel coronavirus...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 the company is now offering a suite of AI solutions Vuno Med-LungQuant and Vuno Med-Chest X-ray for COVID-19, encompassing both lung X-ray and computed tomography (CT) modalities respectively all at once
News | Artificial Intelligence | April 02, 2020
April 2, 2020 — In the face of the COVID-19 pand
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 The Chinese start-up company Infervision launches its AI-based solution InferRead CT Lung Covid-19 also in Europe
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Lung infections generated by the coronavirus can be detected in...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 Doctor in our hospital is using this intelligent system for accurate diagnosis

Doctor in our hospital is using this intelligent system for accurate diagnosis. (Photo: Business Wire)

News | Artificial Intelligence | March 31, 2020
March 31, 2020 — The Intelligent Evalua...
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 behold.ai has developed the artificial intelligence-based red dot algorithm which can identify within 30 seconds abnormalities in chest X-rays. Wellbeing Software operates Cris, a widely used UK radiology Information System (RIS), which is installed in over 700 locations
News | Artificial Intelligence | March 31, 2020
March 31, 2020 — Two British companies at the leading edge of medical imaging technology are working together on a pl